Search Within

Neal Rosen

Formats
  1. Journal Article (226)
  2. Meeting Abstract (186)
  3. Conference Paper (7)
  4. Book Section (2)
  5. Editorial (2)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Breast Medicine Service (426)
  2. Department of Medicine (426)
  3. GSK Faculty (426)
  4. Molecular Pharmacology and Chemistry Program Faculty (426)
  5. Sloan Kettering Institute Faculty (426)
  6. Solid Tumor Oncology Division (426)

More Groups

People
  1. David Solit (155)
  2. Sarat Chandarlapaty (57)
  3. Howard Scher (44)
  4. Christine Pratilas (36)
  5. Elisa De Stanchina (36)
  6. Laura Sepp-Lorenzino (36)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (2)
  4. 2022 (13)
  5. 2021 (13)
  6. 2020 (12)

More Years

Publications
  1. Cancer Research (99)
  2. Clinical Cancer Research (43)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (36)
  4. Cancer Discovery (24)
  5. Journal of Clinical Oncology (23)
  6. Cancer Cell (15)

More Publications

Publishers
  1. American Association for Cancer Research (212)
  2. Nature Publishing Group (38)
  3. American Society of Clinical Oncology (24)
  4. Cell Press (19)
  5. Elsevier Inc. (17)
  6. National Academy of Sciences (11)

More Publishers

Results (426)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
    Meeting Abstract

    Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90
    Meeting Abstract

    Chiosis, G.; Vilenchik, M.; Kim, J.; Aguirre, J.; Rosen, N.
    Annals of Oncology (2005)

    Fulltext@MSK | Save
  • Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel
    Journal Article

    Solit, D. B.; She, Y.; Lobo, J.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer
    Journal Article

    Morris, M. J.; Cordon-Cardo, C.; Kelly, W. K.; Slovin, S. F.; Siedlecki, K.; Regan, K. P.; DiPaola, R. S.; Rafi, M.; Rosen, N.; Scher, H. I.
    Applied Immunohistochemistry & Molecular Morphology (2005)

    Fulltext@MSK | Save
  • Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90
    Journal Article

    Llauger, L.; He, H.; Kim, J.; Aguirre, J.; Rosen, N.; Peters, U.; Davies, P.; Chiosis, G.
    Journal of Medicinal Chemistry (2005)

    Fulltext@MSK | Save
  • Induction of complete regressions of oncogene-induced breast tumors in mice
    Conference Paper

    Benezra, R.; Henke, E.; Ciarrocchi, A.; Ruzinova, M.; Solit, D.; Rosen, N.; Nolan, D.; Mittal, V.; De Candia, P.
    Cold Spring Harbor Laboratory Press (2005)

    Fulltext@MSK | Save
  • The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells
    Journal Article

    She, Qing Bai; Solit, David B.; Ye, Qing; O'reilly, Kathryn E; Lobo, Jose; Rosen, Neal
    Cancer Cell (2005)

    Fulltext@MSK | Save
  • Restoration of PTEN-expression in tumor cells causes them to depend on EGFR for suppression
    Meeting Abstract

    She, Q.; Moasser, M. M.; Ye, Q.; O'reilly, K.; Solit, D.; Rosen, N.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Development of a yeast based system to study the unique properties of mutant androgen receptors which may play a role in prostate cancer progression
    Meeting Abstract

    Robzyk, K.; Oen, H.; Butler, L.; Tilley, W.; Scher, H.; Rosen, N.; Caplan, A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Cyclin D expression and G1 progression are dependent on MEK-MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras and Raf
    Meeting Abstract

    Pratilas, C. A.; Grbovic, O.; Basso, A. D.; Sawai, A.; Chapman, P.; Rosen, N.; Solit, D. B.
    Cancer Research (2004)

    Fulltext@MSK | Save